Showing results (171-180 of 5,696) with videos related to

Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|March 23, 2004
Immunohistochemical analysis of cyclin D1 and p53 in multiple myeloma: relationship to proliferative activity and prognostic significanceO Markovic, D Marisavljevic, V Cemerikic, et al.
Medical Oncology (Northwood, London, England)|January 21, 2022
Who should be treated with pembrolizumab in addition to standard of care in advanced cervical cancer?Seda Kahraman, Ulviye Esra Erbas, Bulent Yalcin
Medical Oncology (Northwood, London, England)|January 21, 2022
Comparative expression analysis of dasatinib and ponatinib-regulated lncRNAs in chronic myeloid leukemia and their network analysisCagla Kayabasi, Ayse Caner, Sunde Yilmaz Susluer, et al.
Medical Oncology (Northwood, London, England)|January 21, 2022
SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signalingTai-Yu Chen, Ji Zhou, Peng-Cheng Li, et al.
Medical Oncology (Northwood, London, England)|January 21, 2022
DNA damage induced cellular senescence and it's PTEN-armed exosomes-the warriors against prostate carcinoma cellsSougata Ghosh Chowdhury, Rachayeeta Ray, Debalina Bhattacharya, et al.
Medical Oncology (Northwood, London, England)|January 4, 2022
OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathwayLi Liu, Changyan Liang, Chenya Zhuo, et al.
Medical Oncology (Northwood, London, England)|January 4, 2022
Mefenamic acid as a promising therapeutic medicine against colon cancer in tumor-bearing miceReza Seyyedi, Fereshteh Talebpour Amiri, Soghra Farzipour, et al.
Medical Oncology (Northwood, London, England)|January 4, 2022
Exosome application in tumorigenesis: diagnosis and treatment of melanomaMohsen Karami Fath, Ali Azargoonjahromi, Nafiseh Jafari, et al.
Medical Oncology (Northwood, London, England)|November 5, 2021
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trialAlice Bonneville-Levard, Didier Frappaz, Olivier Tredan, et al.
Medical Oncology (Northwood, London, England)|October 29, 2022
Evaluation of MMR live attenuated vaccine oncolytic potential using Ehrlich ascites carcinoma in a murine modelSara T Hassan, Aly F Mohamed, Nourhan H AbdelAllah, et al.
Pageof 570